Related Experiment Video

Updated: Mar 6, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.9K

Immunotherapy in pancreatic cancer treatment: a new frontier

Komal Thind1, Leslie J Padrnos2, Ramesh K Ramanathan2

  • 1Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.

Therapeutic Advances in Gastroenterology
|March 14, 2017
PubMed

Insights

Pancreatic cancer is aggressive and treatment-resistant due to its immunosuppressive tumor microenvironment. Immunotherapy offers promising strategies to overcome resistance and improve outcomes for pancreatic cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Pancreatic cancer is a lethal malignancy known for its aggressiveness, invasiveness, and resistance to therapies.
  • Current standard treatments offer limited survival benefits for advanced or metastatic pancreatic cancer.
  • The tumor microenvironment in pancreatic cancer is complex and immunosuppressive, contributing to treatment resistance.

Purpose of the Study:

  • To review current advancements in immunotherapy for pancreatic cancer.
  • To evaluate the effectiveness of novel therapies targeting the tumor microenvironment.
  • To explore immunotherapy as a potential treatment strategy to overcome treatment resistance in pancreatic cancer.

Main Methods:

  • Literature review of preclinical and clinical trials.
  • Analysis of studies focusing on the pancreatic tumor microenvironment.
  • Examination of current immunotherapy approaches and their efficacy.

Main Results:

  • Novel therapies targeting the tumor microenvironment show promising preliminary results.
  • Immunotherapy demonstrates potential in overcoming treatment resistance.
  • Modulating the tumor microenvironment may improve immune tolerance and treatment efficacy.

Conclusions:

  • Immunotherapy represents a promising avenue for treating pancreatic cancer.
  • Targeting the immunosuppressive tumor microenvironment is crucial for enhancing treatment effectiveness.
  • Further research and clinical trials are needed to optimize immunotherapy strategies for pancreatic cancer.
Keywords:
adoptive cellular immunotherapycancer vaccinesimmunotherapypancreatic cancer

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.3K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

13.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K